Bright Minds Biosciences Inc. (DRUG)
DRUG trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | DRUG on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | Canada |
| IPO year | Not reported by the screener |
| SEC CIK | 0001827401 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | BC |
| Canadian listing | CSE: DRUG |
Financials
Foreign filer: no machine-readable annual figure in SEC data.
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 40-F 2025-12-23 |
| Cash and burn | 82.9M CAD cash; operating cash flow -2.2M CAD a quarter. | Report 2025-09-30 |
| Shares outstanding | 7,635,789 (2025-09-30); 4,524,087 a year earlier; 17,592,359 three years earlier. 3y figure adjusted for split (1-for-5 overall); the newest SEC cover-page count is from 2025-09-30; shares issued since then are not in these figures. | Cover page 2025-09-30 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 2 424B5 takedowns, 2 at the market | Latest 2026-01-09 |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | De Visser Gray LLP, Vancouver, Canada | PCAOB Form AP 2026-01-05 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $9.8M on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Annual results
| Fiscal year | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| FY 2025 2025-09-30 | Not filed | -12.2M CAD | -8.7M CAD | 82.9M CAD | No debt tags | Needs four quarters | 40-F 2025-12-23 |
| FY 2024 2024-09-30 | Not filed | -2.8M CAD | -1.9M CAD | 5.7M CAD | No debt tags | Needs four quarters | 20-F 2024-12-31 |
| FY 2023 2023-09-30 | Not filed | -7.4M CAD | -7.0M CAD | 6.7M CAD | No debt tags | Needs four quarters | 20-F 2024-12-31 |
| FY 2022 2022-09-30 | Not filed | -15.0M CAD | -13.6M CAD | 11.6M CAD | No debt tags | Needs four quarters | 20-F 2024-12-31 |
| FY 2021 2021-09-30 | Not filed | -8.7M CAD | -7.3M CAD | 19.8M CAD | No debt tags | Needs four quarters | 20-F 2023-12-29 |
| FY 2020 2020-09-30 | Not filed | -480K CAD | -288K CAD | 800K CAD | No debt tags | Needs four quarters | 20-F 2022-12-29 |
From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months). Amounts in CAD.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document FORM 424B5 | 424B5 | 2026-01-09 |
| Latest annual report FORM 40-F | 40-F | 2025-12-23 |
| Latest quarterly / interim | 6-K | 2026-11-02 |
Source: SEC EDGAR submissions feed, 182 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +0.5% |
| 1 month | -55.0% |
| 3 months | -70.4% |
| Year to date | -70.4% |
| 1 year | -60.4% |
| From 52-week high | -75.9% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| BCYC | Bicycle Therapeutics plc | $3.18 | -5.64% | $222.9M |
| IMRX | Immuneering Corporation | $3.52 | -5.12% | $228.0M |
| VNDA | Vanda Pharmaceuticals Inc. | $3.81 | -4.51% | $230.4M |
| VOGX | Vogenx Inc | $14.38 | -13.74% | $213.6M |
| ACIU | AC Immune SA | $2.09 | -1.88% | $212.7M |
| YARW | Yarrow Bioscience Inc. | $13.93 | -22.74% | $212.2M |
| AMRN | Amarin Corporation plc | $11.31 | -0.62% | $233.4M |
| CYPH | Cypherpunk Technologies Inc. | $1.93 | +2.94% | $207.4M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier